As a Partner at True, Stephanie specializes in Board, CEO, and C-suite level biopharma searches. Her experience building leadership teams with PE/VC investor backed biotech companies to large cap pharma spans discovery research to clinical development, commercial and technical operations, and supporting functions. With a focus in disruptive technologies, her expertise extends to ancillary areas supporting innovation in drug development including digital and data science, diagnostics, and contract research and manufacturing. She joins True with 20 years of dedicated life sciences insight from global practices including Korn Ferry and Spencer Stuart, and therapeutics and device focused boutique executive search firms. Her professional career started in the Healthcare Consulting practice of Cap Gemini/Ernst & Young.
Stephanie is a graduate of Boston College and Emory University, where she completed an MBA at the Goizueta School of Business and MPH in Health Policy and Management at the Rollins School of Public Health.